Skip to main content
Top

Breast Cancer

Issue 2/2012

Content (15 Articles)

Special Feature

Should we treat minimal breast cancer lesions?

Yoshinori Ito

Special Feature

Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer

Kazuhiro Araki, Shigehira Saji, Michelle Gallas, Mark Pegram, Yasutsuna Sasaki

Special Feature

Paradigm shift in axilla surgery for breast cancer patients treated with sentinel node biopsy

Shigeru Imoto, Hirotsugu Isaka, Noriko Sakemura, Hiroki Ito, Kentaro Imi, Kaisuke Miyamoto

Special Feature

The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis

Takeshi Imamura, Atsuhiko Hikita, Yasumichi Inoue

Original Article

CT assessment of breast cancer for pathological involvement of four or more axillary nodes

Ichiro Ogino, Yoshibumi Tayama, Mito Arai, Tomio Inoue, Daisuke Shimizu, Takashi Ishikawa

Original Article

Ultrasonography- and/or mammography-guided breast conserving surgery for ductal carcinoma in situ of the breast: experience with 87 lesions

Naoki Hayashi, Hiroko Tsunoda, Eriko Abe, Mari Kikuchi, Katsutoshi Enokido, Koichiro Tsugawa, Koyu Suzuki, Seigo Nakamura

Original Article

Educational program and testing using images for the standardization of breast cancer screening by ultrasonography

Eriko Tohno, Hidehito Takahashi, Takayuki Tamada, Yasuhisa Fujimoto, Hidemitsu Yasuda, Noriaki Ohuchi

Original Article

Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy

Eri Kawase, Kumiko Karasawa, Sakie Shimotsu, Hiromi Izawa, Hisako Hirowatari, Anneyuko I. Saito, Kana Ito, Naoshi Horikawa

Original Article

High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer

Mohamed Salhab, Neill Patani, Wen Jiang, Kefah Mokbel

Original Article

High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

Eriko Tokunaga, Satoko Okada, Nami Yamashita, Sayuri Akiyoshi, Hiroyuki Kitao, Masaru Morita, Yoshihiro Kakeji, Yoshihiko Maehara

Original Article

Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome

Masako Yamashita, Tomoko Ogawa, Xinhui Zhang, Noriko Hanamura, Yumi Kashikura, Mitsuyuki Takamura, Misao Yoneda, Taizo Shiraishi

Case Report

Squamous cell carcinoma of the breast

Tadahiro Nozoe, Emiko Mori, Mizuki Ninomiya, Takashi Maeda, Akito Matsukuma, Hideaki Nakashima, Takahiro Ezaki

Case Report

Nodular fasciitis of the breast

Tsuguo Iwatani, Hidetaka Kawabata, Daishu Miura, Naoko Inoshita, Yasunori Ohta

Case Report

Breast cancer associated with mammary hamartoma

Masaya Kai, Keiichiro Tada, Miki Tamura, Naoya Gomi, Rie Horii, Futoshi Akiyama, Takuji Iwase

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine